14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:XLRN
Delisted

Acceleron Pharma Inc. Stock Price (Quote)

NASDAQ Stock Exchange
Open Broker Account
$178.75
+0 (+0%)
At Close: May 27, 2022
Forecast Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $178.75 $178.75 Friday, 27th May 2022 XLRN stock ended at $178.75. During the day the stock fluctuated 0% from a day low at $178.75 to a day high of $178.75.
90 days $178.75 $178.75
52 weeks $113.49 $189.99

Historical Acceleron Pharma Inc. prices

Date Open High Low Close Volume
Nov 29, 2021 $178.75 $178.75 $178.75 $178.75 0
Nov 26, 2021 $178.75 $178.75 $178.75 $178.75 0
Nov 24, 2021 $178.75 $178.75 $178.75 $178.75 0
Nov 23, 2021 $178.75 $178.75 $178.75 $178.75 0
Nov 22, 2021 $178.75 $178.75 $178.75 $178.75 0
Nov 19, 2021 $179.68 $179.74 $177.51 $178.75 462 650
Nov 18, 2021 $179.71 $179.78 $179.66 $179.68 1 025 300
Nov 17, 2021 $179.90 $179.94 $179.52 $179.68 6 009 300
Nov 16, 2021 $173.31 $174.50 $173.17 $173.98 840 900
Nov 15, 2021 $173.50 $174.62 $173.43 $173.50 496 501
Nov 12, 2021 $173.30 $173.93 $172.85 $173.11 834 260
Nov 11, 2021 $173.33 $173.80 $173.13 $173.30 480 872
Nov 10, 2021 $174.25 $174.50 $172.90 $173.00 1 416 958
Nov 09, 2021 $174.52 $174.89 $173.87 $173.99 426 489
Nov 08, 2021 $173.50 $174.50 $173.49 $173.71 404 101
Nov 05, 2021 $174.02 $174.25 $172.98 $173.38 520 120
Nov 04, 2021 $172.83 $174.35 $172.83 $173.73 376 351
Nov 03, 2021 $172.68 $173.26 $172.60 $173.03 660 281
Nov 02, 2021 $173.88 $173.89 $172.50 $172.68 925 242
Nov 01, 2021 $174.00 $174.26 $173.33 $173.87 759 358
Oct 29, 2021 $173.91 $174.74 $173.26 $174.18 710 273
Oct 28, 2021 $174.35 $174.37 $173.25 $174.24 1 084 378
Oct 27, 2021 $173.78 $174.51 $173.30 $173.80 594 906
Oct 26, 2021 $173.73 $174.15 $173.50 $173.78 245 755
Oct 25, 2021 $174.41 $174.57 $173.51 $173.78 335 704
Click to get the best stock tips daily for free!

About Acceleron Pharma Inc.

Acceleron Pharma. Acceleron Pharma Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of protein therapeutics for cancer and rare diseases. It is developing sotatercept to treat patients with chronic kidney disease, including mineral-bone disorder, vascular calcification, and anemia; and luspatercept to treat anemia and associated complications in patients with myelodysplastic syndromes and beta-thalassem... XLRN Profile

Golden Star

Ticker Date Change Price
FTSL Apr 18 0.130% $46.22
LNG Apr 17 2.33% $156.81
FCN Apr 16 1.98% $207.62
ELV Apr 16 4.98% $506.97
AKR Apr 05 5.38% $16.53
ITCI Apr 05 8.91% $68.44
SARK Mar 28 17.19% $26.88
ARCC Mar 25 2.68% $20.12
CCK Mar 20 2.77% $77.29
STT Mar 19 2.60% $72.62
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT